Skip to main content

RP n8 (Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 8 mg (base) / 2 mg (base))

Pill with imprint RP n8 is Orange, Round and has been identified as Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 8 mg (base) / 2 mg (base). It is supplied by Rhodes Parmaceuticals L.P..

Buprenorphine/naloxone is used in the treatment of opiate dependence and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 8 mg (base) / 2 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for RP n8

Buprenorphine hydrochloride and naloxone hydrochloride (sublingual) 8 mg (base) / 2 mg (base) RP n8

Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual)

Imprint
RP n8
Strength
8 mg (base) / 2 mg (base)
Color
Orange
Shape
Round
Availability
Prescription only
Drug Class
Narcotic analgesic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
3 - Moderate abuse potential
Labeler / Supplier
Rhodes Parmaceuticals L.P.
Manufacturer
Purdue Pharma L.P.
National Drug Code (NDC)
42858-0602

Get help with Imprint Code FAQs.

Related Images for "RP n8"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.